Clinical Trial Update: A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]

View source ↗

Summary

This document notes an ongoing Phase 1/2 clinical trial by BioNTech evaluating the safety and potential benefit of the investigational combination of BNT326 and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• BNT326
• BNT327

Snippet

Sponsor: BioNTech SE | Conditions: Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: RECRUITING